Home > R&D > HyundaiPharm R&D   
 
Development and sales of competitive new products to create profit and contribute to public health
Continued drive to in-license new products and specific remedies
Development of competitive product through R&D
Increase productivity through outsourcing or forming consortium with domestic and
international companies
Continued drive to in-license new products and specific remedies
-

-
-
Priority Indications : Cardio-Vascular, Respiratory, Endocrinology, CNS, Ob/Gyn, Gastro-Intestinal, Dermatology, and Cancer
Establishment of new international partners and strengthening partnership with existing partners
Decrease the time required for in-licensing and new product sales
Development of competitive product through R&D
-

-
-
-

Development of new QOL (Quality of Life) products, hypertensives, diabetes, Alzheimer’s Disease, Depression, Obesity, Hair loss, etc.
Development of patented products
Development of 1generic products
Development of combination/new formulation products/formulation, increased/new indication, improved posology, improved safety, better absorption, etc.
Increase productivity through outsourcing or forming consortium with domestic and international companies
-
-
-

Establish plans for new clinical and bio-equivalency tests
Establish partnership with academia and research facilities
Organize new production/research/development/marketing/sales outsourcing and consortiums